Oliver T. Keppler, Frank J. Welte, Tuan A. Ngo, Peggy S. Chin, Kathryn S. Patton: Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1. In: Journal of Experimental Medicine. Band195, Nr.6, 18. März 2002, S.719–736, doi:10.1084/jem.20011549, PMID 11901198, PMC 2193739 (freier Volltext).
Christine Goffinet, Ina Allespach, Stefanie Homann, Hanna-Mari Tervo, Anja Habermann: HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor. In: Cell Host & Microbe. Band5, Nr.3, 19. März 2009, S.285–297, doi:10.1016/j.chom.2009.01.009, PMID 19286137.
Christine Goffinet, Ina Allespach, Oliver T. Keppler: HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. In: Proceedings of the National Academy of Sciences. Band104, Nr.3, 16. Januar 2007, S.1015–1020, doi:10.1073/pnas.0607414104, PMID 17209012, PMC 1783356 (freier Volltext).
Hanna-Mari Baldauf, Xiaoyu Pan, Elina Erikson, Sarah Schmidt, Waaqo Daddacha: SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. In: Nature Medicine. Band18, Nr.11, November 2012, S.1682–1688, doi:10.1038/nm.2964, PMID 22972397, PMC 3828732 (freier Volltext).
Hanna-Mari Baldauf, Lena Stegmann, Sarah-Marie Schwarz, Ina Ambiel, Maud Trotard: Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells. In: Proceedings of the National Academy of Sciences. Band114, Nr.10, 22. Februar 2017, S.2729–2734, doi:10.1073/pnas.1613635114, PMID 28228523, PMC 5347584 (freier Volltext).
Constanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, Sarah-Marie Schwarz, Dominique Thomas: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. In: Nature Medicine. Band23, Nr.2, Februar 2017, S.250–255, doi:10.1038/nm.4255.
Thomas Oellerich, Constanze Schneider, Dominique Thomas, Kirsten M. Knecht, Olga Buzovetsky: Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. In: Nature Communications. Band10, Nr.1, Dezember 2019, S.3475, doi:10.1038/s41467-019-11413-4, PMID 31375673, PMC 6677770 (freier Volltext).
Maximilian Muenchhoff, Helga Mairhofer, Hans Nitschko, Natascha Grzimek-Koschewa, Dieter Hoffmann: Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. In: Eurosurveillance. Band25, Nr.24, 18. Juni 2020, S.2001057, doi:10.2807/1560-7917.ES.2020.25.24.2001057, PMID 32583765, PMC 7315722 (freier Volltext).
Andreas Osterman, Hanna-Mari Baldauf, Marwa Eletreby, Jochen M. Wettengel, Suliman Q. Afridi: Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. In: Medical Microbiology and Immunology. Band210, Nr.1, Februar 2021, S.65–72, doi:10.1007/s00430-020-00698-8, PMID 33452927, PMC 7811156 (freier Volltext).
Maximilian Muenchhoff, Alexander Graf, Stefan Krebs, Caroline Quartucci, Sandra Hasmann: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. In: Eurosurveillance. Band26, Nr.43, 28. Oktober 2021, doi:10.2807/1560-7917.ES.2021.26.43.2002066, PMID 34713795, PMC 8555370 (freier Volltext).
Christopher Dächert, Maximilian Muenchhoff, Alexander Graf, Hanna Autenrieth, Sabine Bender: Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. In: Medical Microbiology and Immunology. Band211, Nr.1, Februar 2022, S.71–77, doi:10.1007/s00430-022-00728-7, PMID 35061086, PMC 8780046 (freier Volltext).
Andreas Osterman, Irina Badell, Elif Basara, Marcel Stern, Fabian Kriesel: Impaired detection of omicron by SARS-CoV-2 rapid antigen tests. In: Medical Microbiology and Immunology. 20. Februar 2022, doi:10.1007/s00430-022-00730-z, PMID 35187580, PMC 8858605 (freier Volltext).
Paul R. Wratil, Niklas A. Schmacke, Andreas Osterman, Tobias Weinberger, Jochen Rech: In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers. In: Infection. Band50, Nr.2, 11. August 2021, S.381–394, doi:10.1007/s15010-021-01672-z, PMID 34379308, PMC 8354838 (freier Volltext).
Paul R. Wratil, Niklas A. Schmacke, Burak Karakoc, Alex Dulovic, Daniel Junker: Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses. In: Cell Reports. Band37, Nr.13, Dezember 2021, S.110169, doi:10.1016/j.celrep.2021.110169, PMID 34932974, PMC 8648802 (freier Volltext).
Paul R. Wratil, Marcel Stern, Alina Priller, Annika Willmann, Giovanni Almanzar: Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. In: Nature Medicine. Band28, Nr.3, März 2022, S.496–503, doi:10.1038/s41591-022-01715-4.
Hristo L. Svilenov, Julia Sacherl, Alwin Reiter, Lisa S. Wolff, Cho-Chin Cheng: Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein. In: Antiviral Research. Band196, Dezember 2021, S.105197, doi:10.1016/j.antiviral.2021.105197, PMID 34774603, PMC 8579703 (freier Volltext).
Paul R. Wratil, Marcel Stern, Alina Priller, Annika Willmann, Giovanni Almanzar: Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. In: Nature Medicine. Band28, Nr.3, März 2022, S.496–503, doi:10.1038/s41591-022-01715-4.
Oliver T. Keppler, Frank J. Welte, Tuan A. Ngo, Peggy S. Chin, Kathryn S. Patton: Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1. In: Journal of Experimental Medicine. Band195, Nr.6, 18. März 2002, S.719–736, doi:10.1084/jem.20011549, PMID 11901198, PMC 2193739 (freier Volltext).
Christine Goffinet, Ina Allespach, Stefanie Homann, Hanna-Mari Tervo, Anja Habermann: HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor. In: Cell Host & Microbe. Band5, Nr.3, 19. März 2009, S.285–297, doi:10.1016/j.chom.2009.01.009, PMID 19286137.
Christine Goffinet, Ina Allespach, Oliver T. Keppler: HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. In: Proceedings of the National Academy of Sciences. Band104, Nr.3, 16. Januar 2007, S.1015–1020, doi:10.1073/pnas.0607414104, PMID 17209012, PMC 1783356 (freier Volltext).
Hanna-Mari Baldauf, Xiaoyu Pan, Elina Erikson, Sarah Schmidt, Waaqo Daddacha: SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. In: Nature Medicine. Band18, Nr.11, November 2012, S.1682–1688, doi:10.1038/nm.2964, PMID 22972397, PMC 3828732 (freier Volltext).
Hanna-Mari Baldauf, Lena Stegmann, Sarah-Marie Schwarz, Ina Ambiel, Maud Trotard: Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells. In: Proceedings of the National Academy of Sciences. Band114, Nr.10, 22. Februar 2017, S.2729–2734, doi:10.1073/pnas.1613635114, PMID 28228523, PMC 5347584 (freier Volltext).
Thomas Oellerich, Constanze Schneider, Dominique Thomas, Kirsten M. Knecht, Olga Buzovetsky: Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. In: Nature Communications. Band10, Nr.1, Dezember 2019, S.3475, doi:10.1038/s41467-019-11413-4, PMID 31375673, PMC 6677770 (freier Volltext).
Maximilian Muenchhoff, Helga Mairhofer, Hans Nitschko, Natascha Grzimek-Koschewa, Dieter Hoffmann: Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. In: Eurosurveillance. Band25, Nr.24, 18. Juni 2020, S.2001057, doi:10.2807/1560-7917.ES.2020.25.24.2001057, PMID 32583765, PMC 7315722 (freier Volltext).
Andreas Osterman, Hanna-Mari Baldauf, Marwa Eletreby, Jochen M. Wettengel, Suliman Q. Afridi: Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. In: Medical Microbiology and Immunology. Band210, Nr.1, Februar 2021, S.65–72, doi:10.1007/s00430-020-00698-8, PMID 33452927, PMC 7811156 (freier Volltext).
Maximilian Muenchhoff, Alexander Graf, Stefan Krebs, Caroline Quartucci, Sandra Hasmann: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. In: Eurosurveillance. Band26, Nr.43, 28. Oktober 2021, doi:10.2807/1560-7917.ES.2021.26.43.2002066, PMID 34713795, PMC 8555370 (freier Volltext).
Christopher Dächert, Maximilian Muenchhoff, Alexander Graf, Hanna Autenrieth, Sabine Bender: Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. In: Medical Microbiology and Immunology. Band211, Nr.1, Februar 2022, S.71–77, doi:10.1007/s00430-022-00728-7, PMID 35061086, PMC 8780046 (freier Volltext).
Andreas Osterman, Irina Badell, Elif Basara, Marcel Stern, Fabian Kriesel: Impaired detection of omicron by SARS-CoV-2 rapid antigen tests. In: Medical Microbiology and Immunology. 20. Februar 2022, doi:10.1007/s00430-022-00730-z, PMID 35187580, PMC 8858605 (freier Volltext).
Paul R. Wratil, Niklas A. Schmacke, Andreas Osterman, Tobias Weinberger, Jochen Rech: In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers. In: Infection. Band50, Nr.2, 11. August 2021, S.381–394, doi:10.1007/s15010-021-01672-z, PMID 34379308, PMC 8354838 (freier Volltext).
Paul R. Wratil, Niklas A. Schmacke, Burak Karakoc, Alex Dulovic, Daniel Junker: Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses. In: Cell Reports. Band37, Nr.13, Dezember 2021, S.110169, doi:10.1016/j.celrep.2021.110169, PMID 34932974, PMC 8648802 (freier Volltext).
Hristo L. Svilenov, Julia Sacherl, Alwin Reiter, Lisa S. Wolff, Cho-Chin Cheng: Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein. In: Antiviral Research. Band196, Dezember 2021, S.105197, doi:10.1016/j.antiviral.2021.105197, PMID 34774603, PMC 8579703 (freier Volltext).